🔎 Trials Near Me

መነሻ › አኩት ሊምፎብላስቲክ ሊውኬሚያ › Texas › Houston

በHouston፣ TX ለአኩት ሊምፎብላስቲክ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች

ለአኩት ሊምፎብላስቲክ ሊውኬሚያ የሚደረጉ 28 ጥናቶች በHouston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
እስከ እድሜ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT01853631

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • UT MD Anderson Cancer Center, Houston
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Texas Children's Hospital, Houston
እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Texas MD Anderson Cancer Center, Houston
እድሜ ከ12 እስከ 78 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03802695

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • MD Anderson Cancer Center, Houston
6 Months · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06514794

Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Texas Children's Hospital, Houston
4 Weeks – 18 Years · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06529575

Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT06308588

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Texas Children's Hospital, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT07586618

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
እስከ እድሜ 22 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Baylor Texas Children's Hospital, Houston
እድሜ ከ7 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT05082519

A Study of CTD402 in T-ALL/LBL Patients

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • MD Anderson Cancer Center, Houston
እድሜ 1 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT07070219

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Baylor College of Medicine Houston, Houston
1 Day – 17 Years · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2026 · NCT06274788

Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The University of Texas M. D. Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT07053059

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • M D Anderson Cancer Center, Houston
እድሜ 15 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT03136146

Personalized NK Cell Therapy in CBT

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • M D Anderson Cancer Center, Houston
እድሜ ከ15 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁላይ 2026 · NCT02727803

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Houston
እድሜ 16 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ጁላይ 2026 · NCT07155226

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Houston
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT07109219

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital - Baylor Medical Center, Houston
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT01351545

A Study of Revumenib and Mezigdomide in People With Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • MD Anderson Cancer Center (Data Collection Only), Houston
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT07356154

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • MD Anderson, Houston
እስከ እድሜ 1 · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT05848687

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • M D Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ሜይ 2026 · NCT03263572

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • MD Anderson Cancer Center, Houston
እድሜ 13 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT04771572

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Ascentage Investigative Site #1501, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ኤፕሪ 2026 · NCT06051409

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • MDACC, Houston
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ማርች 2026 · NCT04988555

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • MD Anderson, Houston
እድሜ ከ18 እስከ 66 · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06859424

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኖቬም 2025 · NCT04260022

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Texas Children's Hospital/Baylor College of Medicine, Houston
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ6 ዲሴም 2024 · NCT05476770

በሌሎች ከተሞች ለአኩት ሊምፎብላስቲክ ሊውኬሚያ የሚደረጉ ጥናቶች

በHouston ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።